drugset
drugset / Trial / NCT05236543

A Study to Assess the Pharmacokinetics of AZD4831 When Administered Alone and in Combination With Itraconazole

NCT05236543 ↗

Phase 1 Completed 21 enrolled AstraZeneca Parexel · collab
NaSingle-groupOpen-labelTreatment

Summary

A study to demonstrate pharmacokinetics of AZD4831 when administered alone and in combination with Itraconazole.

Timeline

Start
2022-02-18
Primary completion
2022-08-12
Completion
2022-08-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule — Oral
Subject Mitiperstat Small molecule — Oral

Indications

No indication recorded.